Neuromelanin inhibits CXCL10 expression in human astroglial cells

Increasing evidence indicates neuroinflammation is instrumental in the pathogenesis of Parkinson's disease (PD). In PD, there is selective degeneration of neuromelanin (NM)-containing dopamine neurons. Neuromelanin is predominantly cytoprotective within dopaminergic neurons, whereas, NM released from damaged neurons activates microglia. However, the effects of NM on astroglial cells remain largely unknown. Astroglia are essential to neuronal homeostasis and responsive to injury, in part, through secretion of chemokines, including interferon gamma inducible protein-10 (CXCL10). Thus, we used an in vitro approach to identify the effects of NM on TNF alpha-induced CXCL10 expression in human astroglial cells. TNF alpha-induced CXCL10 expression was inhibited in NM exposed cells. Additionally, TNF alpha-induced NF-kappa B activation was inhibited by NM. Given that CXCL10 expression is NF-kappa B-dependent in human astroglial cells, these findings suggest that NM may inhibit CXCL10 expression, in part, through an NF-kappa B-dependent mechanism. While the in vivo consequences of NM mediated effects on astroglial CXCL10 expression remain to be fully elucidated, insights obtained in this study further our understanding of the effects of NM on inflammatory signaling in human astroglial cells. (C) 2010 Elsevier Ireland Ltd. All rights reserved.